Access to TACE and TARE with respect to region and urbanity in the United States: a large retrospective healthcare claims database study [0.03%]
一项基于大型回顾性医疗保健索赔数据库的美国区域和城镇人口接受TACE和TARE治疗情况的研究
Nathan Sim,John T Moon,Hanzhou Li et al.
Nathan Sim et al.
Access to highly specialized interventional oncology procedures such as transarterial chemoembolization (TACE) and radioembolization (TARE) may be limited in non-metropolitan areas of the United States. This study characterizes the distribu...
Endogenous and extracellular roles of a tumor suppressor miR-379-5p in gastric cancer [0.03%]
胃癌中肿瘤抑制miR-379-5p的内源性和外分泌作用
Michelle Xin Liu,Kent-Man Chu
Michelle Xin Liu
Introduction: MiRNAs play important roles in development of various cancers including gastric cancer. Exosomes are extracellular vesicles for translocating molecules. This study aims to investigate the tumor suppressive r...
Efficacy of Fusion Imaging and Cone-Beam Computed Tomography Guided Radiofrequency Ablation for Hepatocellular Carcinoma Poorly Visualized on Ultrasonography [0.03%]
融合成像和锥形束CT引导经皮射频消融治疗超声显示不佳的肝癌肿瘤的疗效研究
Keizo Kato,Hiroshi Abe,Makiko Ika et al.
Keizo Kato et al.
Introduction: Radiofrequency ablation (RFA) generally involves the insertion of a radiofrequency electrode into the hepatocellular carcinoma (HCC) nodule under ultrasonography (US) guidance. However, the procedure is ofte...
From development to implementation: a systematic review on the current maturity status of artificial intelligence models for patients with colorectal cancer liver metastases [0.03%]
从研发到实施：结直肠癌肝转移患者人工智能模型当前成熟度的系统性回顾
Ruby Kemna,J Michiel Zeeuw,Kirsten A Ziesemer et al.
Ruby Kemna et al.
Introduction Artificial intelligence (AI) is increasingly being researched and developed in the medical field and holds potential to transform healthcare after successful implementation. For patients with colorectal cancer liver metastases ...
Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes [0.03%]
针对胆道癌的抗HER2治疗：疾病位置、HER2状态及生存结果的荟萃分析
Silvia Camera,Margherita Rimini,Silvia Foti et al.
Silvia Camera et al.
Introduction In recent years, the therapeutic scenario of metastatic biliary tract cancers (BTC) beyond first-line has profoundly changed owing to target therapies. HER2 represents a promising molecular target that is frequently altered in ...
Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors [0.03%]
肺癌患者接受免疫检查点抑制剂治疗后发生他汀相关心血管事件及免疫相关不良反应的关系研究
Junmin Song,Kuan-Yu Chi,Hyein Jeon et al.
Junmin Song et al.
Backgrounds: Immune checkpoint inhibitors (ICIs) have improved lung cancer treatment but are associated with an increased risk of cardiotoxicity. We investigated whether statins could mitigate ICI-associated cardiovascula...
Modified albumin-bilirubin grade and alpha-fetoprotein score for predicting prognosis of hepatocellular carcinoma patients undergoing conventional transarterial chemoembolization [0.03%]
改良的白蛋白-胆红素分级和甲胎蛋白评分预测常规肝动脉化疗栓塞治疗肝细胞癌患者预后的价值
Manabu Hayashi,Kazumichi Abe,Tatsuro Sugaya et al.
Manabu Hayashi et al.
Background: Predicting post-treatment prognosis in hepatocellular carcinoma (HCC) patients undergoing conventional transarterial chemoembolization (cTACE) is challenging due to tumor heterogeneity. We here assessed the ut...
Efficacy of locoregional treatment for oligo-drug-resistant lesions during first-line atezolizumab plus bevacizumab therapy for unresectable hepatocellular carcinoma: a single-center retrospective study [0.03%]
阿特朱单抗联合贝伐珠单抗一线治疗不可切除肝细胞癌寡进展病灶局部治疗疗效的单中心回顾性研究
Tasuku Nakabori,Sena Higashi,Kaori Mukai et al.
Tasuku Nakabori et al.
Introduction: Despite recent advancements, outcomes for unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo/bev) remain suboptimal, with drug resistance posing a major challenge. ...
Determining the cut-off value of the MASCC Score to predict mortality in hospitalized febrile neutropenic patients: A decade-long single-center retrospective cohort study [0.03%]
一项十年单中心回顾性队列研究确定MASCC评分预测住院发热性中性粒细胞减少症患者死亡率的截断值
Yasemin Nadir,Pinar Kiran,Damla Erturk et al.
Yasemin Nadir et al.
Introduction: Febrile neutropenia [FN] is linked to significant morbidity and mortality in cancer patients. Therefore, our study aims to determine the cut-off value of the MASCC Score to predict mortality in hospitalized ...